Association mechanism of four acetylcholinesterase inhibitors (AChEIs) with human serum albumin: A biochromatographic approach
Authors:
- Claire AndréCAClaire André
- Mireille ThomassinMTMireille Thomassin
- Yves-Claude GuillaumeYGYves-Claude Guillaume
- 1 December 2008
- journal article
- Published by Elsevier in Journal of Pharmaceutical and Biomedical Analysis
- Vol. 48 (5) , 1345-1350
Abstract
No abstract availableKeywords
This publication has 47 references indexed in Scilit:
- Acetylcholinesterase inhibitors for Alzheimer’s disease: anti-inflammatories in acetylcholine clothing!Age and Ageing, 2006
- Pharmacokinetics in older personsThe American Journal of Geriatric Pharmacotherapy, 2004
- Cholinergic neuropathology in a mouse model of Alzheimer's diseaseJournal of Comparative Neurology, 2003
- Role of the magnesium cation on antihypertensive molecule–human serum albumin binding: affinity chromatography approachJournal of Chromatography B, 2002
- Practical Aspects of the Ligand-Binding and Enzymatic Properties of Human Serum Albumin.Biological and Pharmaceutical Bulletin, 2002
- Donepezil dose-dependently inhibits acetylcholinesterase activity in various areas and in the presynaptic cholinergic and the postsynaptic cholinoceptive enzyme-positive structures in the human and rat brainNeuroscience, 2000
- Molecular Modelling and QSAR of Reversible Acetylcholines-terase InhibitorsCurrent Medicinal Chemistry, 2000
- Crystal structure of human serum albumin at 2.5 Å resolutionProtein Engineering, Design and Selection, 1999
- Atomic structure and chemistry of human serum albuminNature, 1992
- Nerve growth factor potentiates the neurotoxicity of beta amyloid.Proceedings of the National Academy of Sciences, 1990